Page last updated: 2024-09-05

erlotinib hydrochloride and compound 968

erlotinib hydrochloride has been researched along with compound 968 in 1 studies

Compound Research Comparison

Studies (erlotinib hydrochloride)	Trials (erlotinib hydrochloride)	Recent Studies (post-2010) (erlotinib hydrochloride)	Studies (compound 968)	Trials (compound 968)	Recent Studies (post-2010) (compound 968)
4,353	786	3,033	23	0	22

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bao, X; Gan, M; Han, TY; Jin, J; Wang, J; Xie, C; Zhan, WH; Zhang, C	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and compound 968

Article	Year
Inhibition of mitochondrial glutaminase activity reverses acquired erlotinib resistance in non-small cell lung cancer. Oncotarget, 2016, Jan-05, Volume: 7, Issue:1 Topics: Apoptosis; Benzophenanthridines; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Flow Cytometry; Glutaminase; Humans; Lung Neoplasms; Mitochondria; Protein Kinase Inhibitors; RNA Interference; Time Factors	2016

Article

Year

Inhibition of mitochondrial glutaminase activity reverses acquired erlotinib resistance in non-small cell lung cancer.

Oncotarget, 2016, Jan-05, Volume: 7, Issue:1

Topics: Apoptosis; Benzophenanthridines; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Flow Cytometry; Glutaminase; Humans; Lung Neoplasms; Mitochondria; Protein Kinase Inhibitors; RNA Interference; Time Factors

2016